Trump’s Embrace of RFK Jr. Puts Fluoride, Vaccines and Obamacare on the Agenda
Donald Trump’s pledge to let Robert F. Kennedy Jr. “go wild on health” has put three issues on the agenda in the final days of the 2024 campaign.
Related Articles
Dermatology Month in Review | October 2024
In this Month in Review summary, some of the most notable advancements and developments in the field of dermatology were highlighted.
Plant-animal hybrid cells make solar-powered tissues, organs or meat
Scientists in Japan have created hybrid plant-animal cells, essentially making animal cells that can gain energy from sunlight like plants. The breakthrough could have major…
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Vertex Pharmaceuticals raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments.
Tactile Controls Are the Future as Touchscreens Fade Away | AT News
Tactile controls are making a comeback! Many companies are adding physical buttons and knobs back to their devices, moving away from touchscreens that have been…
Tempus buying genetics lab company for $600 million
With Ambry Genetics in tow, Eric Lefkofsky’s biotech startup hopes to accelerate its drive toward turning a profit.
Doctors: To get your patients to share, stop judging them when they do
Opinion: A new study finds that doctors really do judge patients negatively when they share false beliefs.
What’s Next for Psychedelic Medicines? – MedCity News
After the FDA delayed the approval of MDMA-assisted therapy for PTSD, there’s still a way forward for psychedelic medicines, experts said at HLTH.
Green energy plan needs 600 miles of power lines – report
Energy planners say Labour’s 2030 electricity net zero target is “achievable” but a “huge challenge”.
Earlier Detection and Treatment are Essential for Meeting VBC Goals – MedCity News
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in…
Lung Cancer Screening Communication in the US, 2022
This cross-sectional study examines lung cancer screening communication between US clinicians and patients by smoking status and demographic, socioeconomic, and clinical characteristics.
